Gilead Sciences is to trial an inhaled version of remdesivir, a drug which it says shows promise in the treatment of COVID-19.
Inhaled version of ‘promising’ COVID-19 treatment to be trialled
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]